Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

Should You Buy the Dip in Eli Lilly Stock Today?

Eli Lilly (LLY) stock closed notably down on April 24 following reports that its newly launched oral obesity pill, Foundayo, is trailing Novo Nordisk’s (NVO) oral Wegovy in initial uptake. 

Moreover, the IQVIA prescription data for the week ending April 17 showed a modest 0.3% week-over-week decline in total prescriptions across Lilly's broader GLP-1 lineup.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.